ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Performance

ClinicalTrials.gov ID: NCT00711516

Public ClinicalTrials.gov record NCT00711516. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 2:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Double-Blind, Placebo-Controlled, Functional Neuroimaging Study of Armodafinil (200 mg/Day) on Prefrontal Cortical Activation in Patients With Residual Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea

Study identification

NCT ID
NCT00711516
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Cephalon
Industry
Enrollment
40 participants

Conditions and interventions

Interventions

  • Armodafinil Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2008
Primary completion
Aug 31, 2009
Completion
Sep 30, 2009
Last update posted
Jul 18, 2013

2008 – 2009

United States locations

U.S. sites
9
U.S. states
4
U.S. cities
8
Facility City State ZIP Site status
Peninsula Sleep Center Burlingame California 94010
Pacific Research San Diego California 92103
VA San Diego Healthcare System San Diego California 92161
Stanford University Stanford California 94305
Beth Israel Deaconess Medical Boston Massachusetts 12215
Neurocare, Inc. Newton Massachusetts 02459
Washington University St Louis Missouri 63108
Duke University Medical Center Durham North Carolina 27710
Wake Research Associates Raleigh North Carolina 27612

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00711516, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 18, 2013 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00711516 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →